qq
Lv1
30 积分
2023-11-06 加入
-
Latent variable indirect response modeling of clinical efficacy endpoints with combination therapy: application to guselkumab and golimumab in patients with ulcerative colitis
4天前
已完结
-
Complement in human disease: approved and up-and-coming therapeutics
5天前
已完结
-
LIGHT signaling through LTβR and HVEM in keratinocytes promotes psoriasis and atopic dermatitis-like skin inflammation
21天前
已完结
-
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF
1个月前
已完结
-
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1个月前
已完结
-
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
2个月前
已完结
-
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
2个月前
已完结
-
Mechanism by which immune complexes are deposited in hosts tissue
2个月前
已完结
-
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
2个月前
已完结
-
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
2个月前
已完结